Skip to main content
SpringerLink
Log in

Assessment of the Potential Transplant Recipient

  • Chapter
  • First Online:
Practical Nephrology

  • 2405 Accesses

Abstract

Renal transplantation transforms life expectancy in patients with end-stage renal disease (Fig. 66.1). All patients who are considered for renal transplantation require rigorous preoperative assessment in order to ensure their fitness to undergo surgery under general anaesthesia and to optimise the therapeutic impact of a scarce and precious resource. This chapter will review the practical aspects of delivering such an assessment with reference to available evidence and guidelines [1, 2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dudley C, Harden P. Clinical practice guidelines. Assessment of the potential kidney transplant recipient. 5th ed. UK Renal Association; 2010. http://www.renal.org/docs/default-source/guidelines-resources/Assessment_of_the_Potential_Kidney_Transplant_Recipient_-_Final_Version_12_January_2011.pdf?sfvrsn=0.

  2. Kidney Disease: Improving Global Outcomes Transplant Work G. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9 Suppl 3:S1–155.

    Google Scholar 

  3. Wong G, Howard K, Chapman JR, et al. Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS One. 2012;7(1):e29591.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Wang LW, Fahim MA, Hayen A, et al. Cardiac testing for coronary artery disease in potential kidney transplant recipients: a systematic review of test accuracy studies. Am J Kidney Dis. 2011;57(3):476–87.

    Article  PubMed  Google Scholar 

  5. Lentine KL, Hurst FP, Jindal RM, et al. Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies. Am J Kidney Dis. 2010;55(1):152–67.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Welsh RC, Cockfield SM, Campbell P, Hervas-Malo M, Gyenes G, Dzavik V. Cardiovascular assessment of diabetic end-stage renal disease patients before renal transplantation. Transplantation. 2011;91(2):213–8.

    Article  PubMed  Google Scholar 

  7. Kasiske BL, Malik MA, Herzog CA. Risk-stratified screening for ischemic heart disease in kidney transplant candidates. Transplantation. 2005;80(6):815–20.

    Article  PubMed  Google Scholar 

  8. Lewis MS, Wilson RA, Walker KW, et al. Validation of an algorithm for predicting cardiac events in renal transplant candidates. Am J Cardiol. 2002;89(7):847–50.

    Article  PubMed  Google Scholar 

  9. De Lima JJ, Sabbaga E, Vieira ML, et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension. 2003;42(3):263–8.

    Article  PubMed  Google Scholar 

  10. Hage FG, Smalheiser S, Zoghbi GJ, et al. Predictors of survival in patients with end-stage renal disease evaluated for kidney transplantation. Am J Cardiol. 2007;100(6):1020–5.

    Article  PubMed  Google Scholar 

  11. Sharma R, Pellerin D, Gaze DC, et al. Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant. 2005;20(10):2207–14.

    Article  PubMed  Google Scholar 

  12. Boden WE, O’Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503–16.

    Article  CAS  PubMed  Google Scholar 

  13. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351(27):2795–804.

    Article  CAS  PubMed  Google Scholar 

  14. Ricotta JJ, Aburahma A, Ascher E, et al. Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease. J Vasc Surg. 2011;54(3):e1–31.

    Article  PubMed  Google Scholar 

  15. Currie IC, Wilson YG, Baird RN, Lamont PM. Detection of sub-critical arterial stenoses by hyperaemic Doppler. Eur J Vasc Endovasc Surg. 1996;11(1):29–35.

    Article  CAS  PubMed  Google Scholar 

  16. Brekke IB, Lien B, Sodal G, et al. Aortoiliac reconstruction in preparation for renal transplantation. Transpl Int. 1993;6(3):161–3.

    Article  CAS  PubMed  Google Scholar 

  17. AbuRahma AF, Jarrett K, Hayes DJ. Clinical implications of power Doppler three-dimensional ultrasonography. Vascular. 2004;12(5):293–300.

    Article  PubMed  Google Scholar 

  18. El-Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant. 2009;9(3):527–35.

    Article  CAS  PubMed  Google Scholar 

  19. Zimmerhackl LB, Besbas N, Jungraithmayr T, et al. Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome. Semin Thromb Hemost. 2006;32(2):113–20.

    Article  PubMed  Google Scholar 

  20. Canaud G, Zuber J, Sberro R, et al. Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study. Am J Transplant. 2009;9(5):1081–6.

    Article  CAS  PubMed  Google Scholar 

  21. Hickson LJ, Gera M, Amer H, et al. Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence. Transplantation. 2009;87(8):1232–9.

    Article  PubMed  Google Scholar 

  22. Little MA, Dupont P, Campbell E, Dorman A, Walshe JJ. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int. 2006;69(3):504–11.

    Article  CAS  PubMed  Google Scholar 

  23. Shapiro R, Kaplan B. Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients. Am J Transplant. 2011;11(1):10.

    Article  CAS  PubMed  Google Scholar 

  24. Penn I. The effect of immunosuppression on pre-existing cancers. Transplantation. 1993;55(4):742–7.

    Article  CAS  PubMed  Google Scholar 

  25. Johnson SR, Cherikh WS, Kauffman HM, Pavlakis M, Hanto DW. Retransplantation after post-transplant lymphoproliferative disorders: an OPTN/UNOS database analysis. Am J Transplant. 2006;6(11):2743–9.

    Article  CAS  PubMed  Google Scholar 

  26. Milburn H, Ashman N, Davies P, et al. Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease. Thorax. 2010;65(6):557–70.

    Article  PubMed  Google Scholar 

  27. Katz LH, Fraser A, Gafter-Gvili A, Leibovici L, Tur-Kaspa R. Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis. J Viral Hepat. 2008;15(2):89–102.

    CAS  PubMed  Google Scholar 

  28. Chung RT, Feng S, Delmonico FL. Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor. Am J Transplant. 2001;1(2):185–91.

    Article  CAS  PubMed  Google Scholar 

  29. Lee LY, Tong CY, Wong T, Wilkinson M. New therapies for chronic hepatitis C infection: a systematic review of evidence from clinical trials. Int J Clin Pract. 2012;66(4):342–55.

    Article  CAS  PubMed  Google Scholar 

  30. Morales JM, Campistol JM, Dominguez-Gil B, et al. Long-term experience with kidney transplantation from hepatitis C-positive donors into hepatitis C-positive recipients. Am J Transplant. 2010;10(11):2453–62.

    Article  CAS  PubMed  Google Scholar 

  31. Trullas JC, Cofan F, Tuset M, et al. Renal transplantation in HIV-infected patients: 2010 update. Kidney Int. 2011;79(8):825–42.

    Article  CAS  PubMed  Google Scholar 

  32. Stock PG, Barin B, Murphy B, et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med. 2010;363(21):2004–14.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Hoshida Y, Li T, Dong Z, et al. Lymphoproliferative disorders in renal transplant patients in Japan. Int J Cancer. 2001;91(6):869–75.

    Article  CAS  PubMed  Google Scholar 

  34. Kovesdy CP, Czira ME, Rudas A, et al. Body mass index, waist circumference and mortality in kidney transplant recipients. Am J Transplant. 2010;10(12):2644–51.

    Article  CAS  PubMed  Google Scholar 

  35. Potluri K, Hou S. Obesity in kidney transplant recipients and candidates. Am J Kidney Dis. 2010;56(1):143–56.

    Article  PubMed  Google Scholar 

  36. Renders L, Frisman M, Ufer M, et al. CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients. Clin Pharmacol Ther. 2007;81(2):228–34.

    Article  CAS  PubMed  Google Scholar 

  37. Gervasini G, Garcia M, Macias RM, Cubero JJ, Caravaca F, Benitez J. Impact of genetic polymorphisms on tacrolimus pharmacokinetics and the clinical outcome of renal transplantation. Transpl Int. 2012;25(4):471–80.

    Article  CAS  PubMed  Google Scholar 

  38. Power RE, Hickey DP, Little DM. Urological evaluation prior to renal transplantation. Transplant Proc. 2004;36(10):2962–7.

    Article  CAS  PubMed  Google Scholar 

  39. Oliver M, Woywodt A, Ahmed A, Saif I. Organ donation, transplantation and religion. Nephrol Dial Transplant. 2011;26(2):437–44.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Imperial College London, Room 5N8A, Commonwealth Building, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK

    Albert Power MB, BChir, MRCP, MD

  2. UCL Centre for Nephrology, Royal Free Hospital, Pond Street, London, NW3 2QG, UK

    Peter J. Dupont PhD, FRCPI

Authors
  1. Albert Power MB, BChir, MRCP, MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter J. Dupont PhD, FRCPI
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Albert Power MB, BChir, MRCP, MD .

Editor information

Editors and Affiliations

  1. UCL Department of Nephrology, Royal Free London NHS Foundation Trust, London, United Kingdom

    Mark Harber

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Power, A., Dupont, P.J. (2014). Assessment of the Potential Transplant Recipient. In: Harber, M. (eds) Practical Nephrology. Springer, London. https://doi.org/10.1007/978-1-4471-5547-8_66

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-5547-8_66

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-5546-1

  • Online ISBN: 978-1-4471-5547-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation